![]() |
市場調査レポート
商品コード
1701098
組織切片作製の市場規模、シェア、成長分析:製品別、技術別、材料タイプ別、用途別、最終用途別、地域別 - 産業予測 2025~2032年Tissue Sectioning Market Size, Share, and Growth Analysis, By Product (Instruments, Accessories & Consumables), By Technology (Automatic, Semiautomatic), By Material Type, By Application, By End-Use, By Region - Industry Forecast 2025-2032 |
||||||
|
組織切片作製の市場規模、シェア、成長分析:製品別、技術別、材料タイプ別、用途別、最終用途別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
組織切片作製の世界市場規模は2023年に5億9,486万米ドルとなり、予測期間(2025~2032年)のCAGRは10.8%で、2024年の6億5,910万米ドルから2032年には14億9,718万米ドルに成長する見通しです。
組織切片作製市場はヘルスケアとライフサイエンスにとって極めて重要であり、研究、診断、治療戦略の進歩を促進します。主な動向は、がんや神経疾患などの慢性疾患の罹患率上昇に後押しされ、堅調な成長を示しています。組織切片作製は、薄い組織サンプルの詳細な検査を可能にし、病気の進行の理解や治療効果の評価に不可欠な病理組織学や分子生物学のアプリケーションをサポートします。特に自動化されたハイスループット・システムにおける技術革新は、精度と効率を高め、潜在的な診断ミスを最小限に抑えています。さらに、個別化医療や精密診断の需要が高まるにつれて、精密な組織分析の重要性が高まり、オーダーメイドの治療計画を策定し、患者の治療成績を向上させる上で、組織切片作製が不可欠な役割を担っています。
Global Tissue Sectioning Market size was valued at USD 594.86 million in 2023 and is poised to grow from USD 659.1 million in 2024 to USD 1497.18 million by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).
The Tissue Sectioning Market is crucial to healthcare and life sciences, driving advancements in research, diagnostics, and treatment strategies. Key trends indicate robust growth, primarily fueled by the rising incidence of chronic diseases, including cancer and neurological disorders. Tissue sectioning enables detailed examination of thin tissue samples, supporting applications in histopathology and molecular biology, vital for understanding disease progression and evaluating treatment efficacy. Technological innovations, particularly in automated and high-throughput systems, are enhancing accuracy and efficiency, minimizing potential diagnostic errors. Moreover, as the demand for personalized medicine and precision diagnostics grows, the importance of precise tissue analysis escalates, solidifying tissue sectioning's integral role in developing tailored treatment plans and improving patient care outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tissue Sectioning Market Segments Analysis
Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Tissue Sectioning Market
The increasing incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, has emerged as a major catalyst for the growth of the global tissue sectioning market. This essential technique in pathology and research plays a vital role in the diagnosis and comprehension of these medical conditions. With an aging global population and a corresponding rise in the prevalence of chronic diseases, there is a surging demand for tissue sectioning tools and services. Consequently, the tissue sectioning market is experiencing substantial growth, driven by the urgent need for precise diagnostic methods to address these health challenges.
Restraints in the Global Tissue Sectioning Market
The Global Tissue Sectioning market faces notable constraints primarily due to the high costs associated with advanced automated tissue sectioning equipment. This financial burden can deter smaller laboratories, clinics, and research institutions that operate on tight budgets from investing in such technology. The substantial initial expenses related to both the purchase and maintenance of these advanced systems can obstruct their widespread adoption, particularly in environments with limited financial resources. Consequently, the financial barriers presented by the pricing of tissue sectioning equipment may hinder technological advancements and limit access to quality tissue sectioning solutions in various healthcare and research settings.
Market Trends of the Global Tissue Sectioning Market
The Global Tissue Sectioning market is witnessing a transformative shift driven by the automation and digitization of tissue sectioning processes. Automated equipment, including advanced microtomes and cryostats, significantly enhances workflow efficiency and precision, thereby minimizing cross-contamination risks. This increase in automation is complemented by a notable trend towards digitizing tissue samples, fostering improved storage, analysis, and interoperability among pathology laboratories. The rise of digital pathology systems, integrated with sophisticated image analysis software, is making it easier for researchers and clinicians to access and interpret tissue data, ultimately propelling advancements in diagnostics and personalized medicine within a fast-evolving marketplace.